|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Tracking Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| First Received Date ICMJE | July 3, 2001 | ||||||||||||
| Last Updated Date | January 20, 2009 | ||||||||||||
| Start Date ICMJE | October 1999 | ||||||||||||
| Primary Completion Date | |||||||||||||
| Current Primary Outcome Measures ICMJE | |||||||||||||
| Original Primary Outcome Measures ICMJE | |||||||||||||
| Change History | Complete list of historical versions of study NCT00018382 on ClinicalTrials.gov Archive Site | ||||||||||||
| Current Secondary Outcome Measures ICMJE | |||||||||||||
| Original Secondary Outcome Measures ICMJE | |||||||||||||
| Descriptive Information | |||||||||||||
| Brief Title ICMJE | Insulin, Neurogenetics and Memory in Alzheimer's Disease | ||||||||||||
| Official Title ICMJE | Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach | ||||||||||||
| Brief Summary | This study examines the use of insulin-sensitizing compounds, as therapeutic agents for cognitive impairment in Alzheimer's disease. |
||||||||||||
| Detailed Description | |||||||||||||
| Study Phase | Phase II | ||||||||||||
| Study Type ICMJE | Interventional | ||||||||||||
| Study Design ICMJE | Treatment, Randomized, Double-Blind, Placebo Control, Efficacy Study | ||||||||||||
| Condition ICMJE | Alzheimer Disease | ||||||||||||
| Intervention ICMJE | Drug: rosiglitazone | ||||||||||||
| Study Arms / Comparison Groups | |||||||||||||
| Publications * | |||||||||||||
|
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||||||||||
| Recruitment Information | |||||||||||||
| Recruitment Status ICMJE | Completed | ||||||||||||
| Enrollment ICMJE | |||||||||||||
| Completion Date | March 2003 | ||||||||||||
| Primary Completion Date | |||||||||||||
| Eligibility Criteria ICMJE | Men and women with mild Alzheimer's Disease without serious medical or psychiatric comorbid conditions. |
||||||||||||
| Gender | Both | ||||||||||||
| Ages | 55 Years to 80 Years | ||||||||||||
| Accepts Healthy Volunteers | No | ||||||||||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||||||||||
| Location Countries ICMJE | United States | ||||||||||||
| Administrative Information | |||||||||||||
| NCT ID ICMJE | NCT00018382 | ||||||||||||
| Responsible Party | |||||||||||||
| Study ID Numbers ICMJE | AGCG-012-98S | ||||||||||||
| Study Sponsor ICMJE | Department of Veterans Affairs | ||||||||||||
| Collaborators ICMJE | |||||||||||||
| Investigators ICMJE |
|
||||||||||||
| Information Provided By | Department of Veterans Affairs | ||||||||||||
| Verification Date | December 2004 | ||||||||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||||||||||
